Eruptive melanocytic acral nevi in the setting of 6-mercaptopurine therapy

Arpan V. Prabhu, Kristin Bibee, Joseph C. English

Research output: Contribution to journalArticlepeer-review

Abstract

Eruptive melanocytic nevi (EMN) are a rare clinical finding characterized by sudden-onset nevi that often present in a grouped distribution. They have been associated with chemotherapy, immunosuppression, bullous diseases, and medications including multikinase and BRAF inhibitors. It is important for dermatologists to be able to identify patients with sudden development of new melanocytic nevi secondary to particular medications. Herein, we describe a case of eruptive melanocytic acral nevi secondary to 6-mercaptopurine therapy.

Original languageEnglish (US)
Pages (from-to)516-518
Number of pages3
JournalJournal of Drugs in Dermatology
Volume16
Issue number5
StatePublished - May 2017
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Eruptive melanocytic acral nevi in the setting of 6-mercaptopurine therapy'. Together they form a unique fingerprint.

Cite this